| 13th week of 2021 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20210093592 | SYSTEMS AND METHODS FOR TREATING VITILIGO | 2021-04-01 |
| 20210093593 | ANTISEPTIC, ANTISEBORRHEIC AND EXFOLIATING COMPOSITION TO REMOVE OR PREVENT ACNE | 2021-04-01 |
| 20210093594 | SKIN CONDITION IMPROVING AGENTS | 2021-04-01 |
| 20210093595 | NON-PHARMACEUTICAL BACTERICIDAL COMPOSITION AGAINST HELICOBACTER PYLORI | 2021-04-01 |
| 20210093596 | NON-PHARMACEUTICAL BACTERICIDAL COMPOSITION AGAINST HELICOBACTER PYLORI | 2021-04-01 |
| 20210093597 | KRAS Agonists, Pharmaceutical Compositions, and Uses in Managing Cancer | 2021-04-01 |
| 20210093598 | STORAGE STABLE AQUEOUS PARENTERAL SOLUTIONS COMPRISING DICLOFENAC | 2021-04-01 |
| 20210093599 | N-ACETYLCYSTEINE ATTENUATES AORTIC STENOSIS PROGRESSION BY INHIBITING SHEAR-MEDIATED TGF-BETA ACTIVATION AND SIGNALING | 2021-04-01 |
| 20210093600 | COMPOSITION FOR TREATING DIABETES MELLITUS AND DIABETES ANALYSIS METHOD | 2021-04-01 |
| 20210093601 | PREVENTION OR REMEDIATION COMPOSITION FOR DEMENTIA OR DEPRESSION | 2021-04-01 |
| 20210093602 | METABOLIC THERAPY FOR WOUND HEALING | 2021-04-01 |
| 20210093603 | CARBAMOYL PHENYLALANINOL ANALOGS AND USES THEREOF | 2021-04-01 |
| 20210093604 | METHOD OF TREATING PATIENTS WITH A FACTOR Xa INHIBITOR, ASPIRIN, AND VERAPAMIL | 2021-04-01 |
| 20210093605 | METHODS FOR TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS | 2021-04-01 |
| 20210093606 | COMPOUNDS AND USES THEREOF | 2021-04-01 |
| 20210093607 | ANTITUMOR NANO-DRUG | 2021-04-01 |
| 20210093608 | SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV | 2021-04-01 |
| 20210093609 | USE OF MAVOGLURANT IN THE REDUCTION OF COCAINE USE OR IN PREVENTING RELAPSE INTO COCAINE USE | 2021-04-01 |
| 20210093610 | (3AR)-1,3A,8-TRIMETHYL-1 ,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL PHENYLCARBAMATE AND METHODS OF TREATING OR PREVENTING NEURODEGENERATION | 2021-04-01 |
| 20210093611 | COMPOUNDS USEFUL AS KINASE INHIBITORS | 2021-04-01 |
| 20210093612 | SYSTEMS AND METHODS TO TREAT PAIN LOCALLY | 2021-04-01 |
| 20210093613 | DIAZOLE LACTAMS | 2021-04-01 |
| 20210093614 | MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY | 2021-04-01 |
| 20210093615 | Apparatus And Method For Forming Melt-Formed Inorganic Fibres | 2021-04-01 |
| 20210093616 | PHARMACEUTICAL COMPOSITIONS | 2021-04-01 |
| 20210093617 | Method of Treating Cancer With Atpenin A5 Derviatives | 2021-04-01 |
| 20210093618 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | 2021-04-01 |
| 20210093619 | Chemical Compounds as ATF-4 Pathway Inhibitors | 2021-04-01 |
| 20210093620 | Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate Cancer | 2021-04-01 |
| 20210093621 | METHOD OF TREATMENT WITH TRADIPITANT | 2021-04-01 |
| 20210093622 | USE OF PRIDOPIDINE FOR THE TREATMENT OF ANXIETY AND DEPRESSION | 2021-04-01 |
| 20210093623 | Methylphenidate Extended Release Chewable Tablet | 2021-04-01 |
| 20210093624 | Chemical Synthesis of Clopidogrel Active Metabolites and Disulfide Conjugate Prodrugs | 2021-04-01 |
| 20210093625 | COMBINATION THERAPY | 2021-04-01 |
| 20210093626 | SERPIN INHIBITORS FOR THE TREATMENT OF PRION AND PRION-LIKE DISEASES | 2021-04-01 |
| 20210093627 | MEDICAL TREATMENTS BASED ON ANAMORELIN | 2021-04-01 |
| 20210093628 | TESOFENSINE AND METOPROLOL FOR TREATMENT OF HYPERTENSION | 2021-04-01 |
| 20210093629 | GLUTAMATE AGENTS IN THE TREATMENT OF MENTAL DISORDERS | 2021-04-01 |
| 20210093630 | GLUTAMATE AGENTS IN THE TREATMENT OF MENTAL DISORDERS | 2021-04-01 |
| 20210093631 | Therapeutic Uses of Compounds Having Combined Sert, 5-HT3 and 5-HT1a Activity | 2021-04-01 |
| 20210093632 | GERANYLGERANYLTRANSFERASE I INHIBITOR FOR TREATMENT OF A PTEN DEFECTIVE CANCER | 2021-04-01 |
| 20210093633 | TREATMENT FOR DIABETES IN PATIENTS INAPPROPRIATE FOR METFORMIN THERAPY | 2021-04-01 |
| 20210093634 | NOVEL METHODS | 2021-04-01 |
| 20210093635 | METHODS FOR CONTROLLED PROLIFERATION OF STEM CELLS / GENERATING INNER EAR HAIR CELLS USING 2-PYRIMIDINYLAMINOETHYLAMINO-2-PYRIDYL BASED COMPOUNDS | 2021-04-01 |
| 20210093636 | Arylamide compounds and compositions and uses thereof | 2021-04-01 |
| 20210093637 | TOPICAL OINTMENT FORMULATIONS OF PDE-4 INHIBITOR AND THEIR USE IN TREATING SKIN CONDITIONS | 2021-04-01 |
| 20210093638 | TREATMENT OF B-CELL MALIGNANCIES BY A COMBINATION JAK AND PI3K INHIBITORS | 2021-04-01 |
| 20210093639 | CONTROLLED-RELEASE TOZADENANT FORMULATIONS | 2021-04-01 |
| 20210093640 | Polycyclic Carbamoylpyridone Derivatives, Pharmaceutical Compositions and Use Thereof | 2021-04-01 |
| 20210093641 | SKIN-PENETRATING FORMULATION OF TAUROLIDINE | 2021-04-01 |
| 20210093642 | STABLE AQUEOUS PARENTERAL SOLUTIONS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) | 2021-04-01 |
| 20210093643 | 18-MC FOR TREATMENT OF SUBSTANCE USE DISORDERS | 2021-04-01 |
| 20210093644 | ACETAMIDE THIENOTRIAZOLODIAZEPINES AND USES THEREOF | 2021-04-01 |
| 20210093645 | COMBINATION ANTI CANCER THERAPY WITH AN IAP ANTAGONIST AND AN ANTI PD-1 MOLECULE | 2021-04-01 |
| 20210093646 | TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH | 2021-04-01 |
| 20210093647 | BETULIN-CONTAINING BIRCH BARK EXTRACTS AND THEIR FORMULATION | 2021-04-01 |
| 20210093648 | COMPOSITIONS THAT PREFERENTIALLY POTENTIATE SUBTYPES OF GABAA RECEPTORS AND METHODS OF USE THEREOF | 2021-04-01 |
| 20210093649 | PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR | 2021-04-01 |
| 20210093650 | NOVEL ANTIVIRAL NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR | 2021-04-01 |
| 20210093651 | COMPOSITION FOR IMPROVING SKIN ELASTICITY COMPRISING NOVEL GINSENOSIDE | 2021-04-01 |
| 20210093652 | COMPOSITIONS AND METHODS OF POTENTIATING ANTIMICROBIALS | 2021-04-01 |
| 20210093653 | COMPOSITION FOR PREVENTING OR IMPROVING MENOPAUSAL SYMPTOM COMPRISING NOVEL GINSENOSIDE | 2021-04-01 |
| 20210093654 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LIVER CANCER | 2021-04-01 |
| 20210093655 | Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders | 2021-04-01 |
| 20210093656 | Composition of Novel Carbohydrate Drug for Treatment of Human Diseases | 2021-04-01 |
| 20210093657 | COMPOSITIONS AND METHODS FOR TREATING EYE DISEASES | 2021-04-01 |
| 20210093658 | Methods and Compositions for the Treatment of Pain and/or Inflammation | 2021-04-01 |
| 20210093659 | METHOD OF BOWEL PREPARATION FOR COLONOSCOPY | 2021-04-01 |
| 20210093660 | COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR THE HYPOXIA RESPONSE FOR TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS | 2021-04-01 |
| 20210093661 | COMPOSITIONS OF AND METHODS FOR DAIRY ANIMAL TEAT DIP | 2021-04-01 |
| 20210093662 | Gold Particle for Use in Therapy to Prevent Scar Formation | 2021-04-01 |
| 20210093663 | PHARMACEUTICAL COMPOSITION FOR IMPROVING HEALTH, CURE ABNORMALITIES AND DEGENERATIVE DISEASE, ACHIEVE ANTI-AGING EFFECT OF THERAPY AND THERAPEUTIC EFFECT ON MAMMALS AND METHOD THEREOF | 2021-04-01 |
| 20210093664 | TRACE ELEMENT SOLUTION | 2021-04-01 |
| 20210093665 | CHIMERIC ANTIGEN RECEPTORS AGAINST SENESCENT CELLS AND USES THEREOF | 2021-04-01 |
| 20210093666 | CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND SECONDARY EFFECTORS AND USES THEREOF | 2021-04-01 |
| 20210093667 | CRISPR/CAS-ADENINE DEAMINASE BASED COMPOSITIONS, SYSTEMS, AND METHODS FOR TARGETED NUCLEIC ACID EDITING | 2021-04-01 |
| 20210093668 | NUCLEIC ACID CONSTRUCTS COMPRISING GENE EDITING MULTI-SITES AND USES THEREOF | 2021-04-01 |
| 20210093669 | Primary T-Cell Expansion | 2021-04-01 |
| 20210093670 | MATERIALS AND METHODS FOR THE TREATMENT OF LEWY BODY DISORDERS | 2021-04-01 |
| 20210093671 | USE OF MICROVESICLES DERIVED FROM STEM CELLS IN TREATMENT OF NEUROINFLAMMATION, PARTICULARLY INDUCED BY STROKE | 2021-04-01 |
| 20210093672 | Placental Tissue Grafts And Improved Methods Of Preparing And Using The Same | 2021-04-01 |
| 20210093673 | Method For Separation Of Dopaminergic Neural Cells And Pharmaceutical Composition Comprising Dopaminergic Neural Cells For Treatment Of Parkinson's Disease | 2021-04-01 |
| 20210093674 | Cell Composition, Method of Production and its Use in Corneal Diseases | 2021-04-01 |
| 20210093675 | PLACENTAL TISSUE COMPONENT COMPOSITIONS FOR TREATMENT OF SKIN DEFECTS AND METHODS USING SAME | 2021-04-01 |
| 20210093676 | SOMATIC STEM CELLS FOR TREATING BONE DEFECTS | 2021-04-01 |
| 20210093677 | NANOVESICLES DERIVED FROM FAECALIBACTERIUM PRAUSNITZII AND USES THEREOF | 2021-04-01 |
| 20210093678 | COMPOSITION FOR PREVENTING, IMPROVING, OR TREATING AUTISM SPECTRUM DISORDERS INCLUDING AGATHOBACULUM SP. STRAIN AS ACTIVE INGREDIENT | 2021-04-01 |
| 20210093679 | ENGINEERED GUT MICROBES AND USES THEREOF | 2021-04-01 |
| 20210093680 | COMPOSITIONS AND METHODS OF TREATING CANCER USING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS | 2021-04-01 |
| 20210093681 | Compositions and Methods Comprising a Defined Microbiome and Methods of Use Thereof | 2021-04-01 |
| 20210093682 | Lactobacillus Gasseri KBL697 Strain and Use Thereof | 2021-04-01 |
| 20210093683 | HERPES 2 ANTIBODY SYSTEM | 2021-04-01 |
| 20210093684 | PLATFORM ONCOLYTIC VECTOR FOR SYSTEMIC DELIVERY | 2021-04-01 |
| 20210093685 | Kapok Tree Flower Extract, And Cosmetic, Pharmaceutical Or Dermatological Compositions Containing Same | 2021-04-01 |
| 20210093686 | SINGLE HERB EXTRACT FOR THE TREATMENT OF PCOS (POLY CYSTIC OVARIAN SYNDROME) | 2021-04-01 |
| 20210093687 | Composition for the Modulation of Circadian Rhythmicity and Sleep Quality | 2021-04-01 |
| 20210093688 | HEART-PROTECTIVE PLANT PREPARATION FOR PREVENTING AND IMPROVING CORONARY HEART DISEASE | 2021-04-01 |
| 20210093689 | Sincalide Formulations | 2021-04-01 |
| 20210093690 | TOPICAL ANTIBIOTIC | 2021-04-01 |
| 20210093691 | Glycopeptide Compounds Having Activity Of Resisting Drug-Resistant Bacteria, And Preparation Method And Application Thereof | 2021-04-01 |
